Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Thermo Fisher Scientific
  6. Summary
    TMO   US8835561023

THERMO FISHER SCIENTIFIC

(TMO)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
11/26/2021 11/29/2021 11/30/2021 12/01/2021 12/02/2021 Date
638.74(c) 648.77(c) 632.83(c) 626.15(c) 627.58(c) Last
1 677 730 1 869 937 2 562 961 1 502 852 1 481 709 Volume
+0.91% +1.57% -2.46% -1.06% +0.23% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 37 181 M - -
Net income 2021 7 605 M - -
Net Debt 2021 25 683 M - -
P/E ratio 2021 33,0x
Yield 2021 0,16%
Sales 2022 40 685 M - -
Net income 2022 7 041 M - -
Net Debt 2022 21 493 M - -
P/E ratio 2022 34,5x
Yield 2022 0,17%
Capitalization 247 B 247 B -
EV / Sales 2021 7,34x
EV / Sales 2022 6,61x
Nbr of Employees 80 000
Free-Float 89,6%
More Financials
Company
Thermo Fisher Scientific Inc. develops, manufactures and sells a range of products. The Company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. It offers its products and services through various brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services. Life Sciences... 
Read more
More about the company
Ratings of Thermo Fisher Scientific
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B+
More Ratings
All news about THERMO FISHER SCIENTIFIC
02:33aUK Regulator Won't Refer Thermo Fisher's Acquisition of PPD for Further Review
DJ
12/01New High Fidelity CRISPR Cas9 Protein Reduces Off-target Effects for More Precise Genom..
AQ
11/29Thermo Fisher says its COVID-19 tests accurately detects Omicron variant
RE
11/29ETF PREVIEW : ETFs, Futures Inch Higher as Wall Street Mulls New Omicron COVID-19 Variant,..
MT
11/29Thermo Fisher Scientific Says Its COVID-19 TaqPath Tests Can Accurately Detect Omicron ..
MT
11/29Thermo Fisher Scientific Confirms Detection of SARS-CoV-2 in Samples Containing the Omi..
PR
11/29REFILE-Thermo Fisher says its COVID-19 tests accurately detects Omicron variant
RE
11/22Biocept Launches Combined COVID-19, Influenza Test; COVID-19 Test Developed With Aegea ..
MT
11/18THERMO FISHER SCIENTIFIC INC. : Entry into a Material Definitive Agreement, Regulation FD ..
AQ
11/18Thermo Fisher Scientific Announces Redemption of Senior Notes
PR
11/18Thermo Fisher Scientific Inc. Announces Redemption of Senior Notes
CI
11/15Thermo Fisher Scientific Selects Mebane, N.C. as Site for New Manufacturing Facility
AQ
11/15Cellenion Announces Co-Marketing Agreement for Single Cell Mass Spectrometry-Based Prot..
AQ
11/15Cellenion Announces Co-Marketing Agreement for Single Cell Mass Spectrometry-Based Prot..
CI
11/12Thermo Fisher Scientific Selects Mebane, N.C. as Site for New Manufacturing Facility
CI
More news
News in other languages on THERMO FISHER SCIENTIFIC
11/29APERÇU DES ETF : Les ETF et les contrats à terme progressent alors que la Bourse s'intéres..
11/22Biocept lance un test combiné COVID-19, grippe ; le test COVID-19 développé avec Aegea ..
11/16Neue Spekulationen treiben Qiagen auf 21-Jahreshoch
11/04Thermo Fisher Scientific Inc. Déclare un dividende trimestriel, payable le 14 janvier 2..
11/04Qiagen hebt Jahresziele wieder an - Überraschend starkes Quartal
More news
Analyst Recommendations on THERMO FISHER SCIENTIFIC
More recommendations
Analysis
Thermo Fisher set to benefit from demand for testing kits, vaccines
Chart THERMO FISHER SCIENTIFIC
Duration : Period :
Thermo Fisher Scientific Technical Analysis Chart | TMO | US8835561023 | MarketScreener
Technical analysis trends THERMO FISHER SCIENTIFIC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 22
Last Close Price 627,58 $
Average target price 668,10 $
Spread / Average Target 6,46%
EPS Revisions
Managers and Directors
Marc N. Casper Chairman, President & Chief Executive Officer
Stephen Williamson Chief Financial Officer & Senior Vice President
Ryan Snyder Chief Information Officer & Senior Vice President
Alan B. Sachs Chief Medical Officer
Karen E. Nelson Chief Scientific Officer
Sector and Competitors
1st jan.Capi. (M$)
THERMO FISHER SCIENTIFIC34.43%247 297
DANAHER CORPORATION42.28%225 849
INTUITIVE SURGICAL, INC.20.03%116 931
SIEMENS HEALTHINEERS AG52.50%81 212
EDWARDS LIFESCIENCES CORPORATION20.38%68 564
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.-18.92%65 685